sarcoma
Count Me In, Genome Medical Team up on Genetic Services for Rare Cancer Research Projects
Qualifying participants in two projects will be referred to Genome Medical for genetic counseling and will be offered optional clinical germline genetic testing.
Carrick Therapeutics Advances Second CDK Inhibitor Into Clinic, Explores Biomarker Approaches
Premium
The Boston-based firm just launched the first trial of a CDK12/13 inhibitor and is anticipating starting Phase III trials for a CDK7 inhibitor in 2026.
FDA Clears Medigene's IND for TCR-T Therapy in Certain Advanced Solid Tumors
The firm plans to launch a Phase I trial for the autologous TCR-T cell therapy by year-end if additional funding comes through.
'The Lead That Starts the Avalanche': Second Solid Tumor Cell Therapy Approval Energizes the Field
Premium
Adaptimmune's recent Tecelra approval further bolsters confidence in the feasibility of commercial approval for autologous cell therapies in solid tumors.
FDA Approves Adaptimmune's TCR Therapy Tecelra for Certain Synovial Sarcoma Patients
The accelerated approval marks the first time the FDA has approved an engineered autologous cell therapy for a solid tumor indication.
Jun 29, 2022
May 25, 2022